{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:14:01Z","timestamp":1783559641050,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011576","name":"In\u00f6n\u00fc \u00dcniversitesi","doi-asserted-by":"publisher","award":["2016\/164"],"award-info":[{"award-number":["2016\/164"]}],"id":[{"id":"10.13039\/501100011576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52769-0","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:52:59Z","timestamp":1778406779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of vinpocetine in an acute doxorubicin-induced cardiotoxicity model in rats"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-3118","authenticated-orcid":false,"given":"Abdullah","family":"Ercan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-4213","authenticated-orcid":false,"given":"Mehmet Ediz","family":"Sarihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9018-7849","authenticated-orcid":false,"given":"Onural","family":"Ozhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6781-7478","authenticated-orcid":false,"given":"Necip","family":"Ermis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-7867","authenticated-orcid":false,"given":"Azibe","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-1696","authenticated-orcid":false,"given":"Nigar","family":"Vardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-7942","authenticated-orcid":false,"given":"Merve","family":"Durhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-0946","authenticated-orcid":false,"given":"Yilmaz","family":"Cigremis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-098X","authenticated-orcid":false,"given":"Cemil","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-3468","authenticated-orcid":false,"given":"Hakan","family":"Parlakpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"52769_CR1","first-page":"411","volume":"6","author":"J Wojtacki","year":"2000","unstructured":"Wojtacki, J., Lewicka-Nowak, E. & Le\u015bniewski-Kmak, K. Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention\u2013review of the literature. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 6, 411\u2013420 (2000).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"52769_CR2","doi-asserted-by":"publisher","unstructured":"Bhutani, V. et al. Doxorubicin-induced cardiotoxicity: A comprehensive update. J. Cardiovasc. Dev. Dis. 12 https:\/\/doi.org\/10.3390\/jcdd12060207 (2025).","DOI":"10.3390\/jcdd12060207"},{"key":"52769_CR3","doi-asserted-by":"publisher","unstructured":"Chandimali, N. et al. Free radicals and their impact on health and antioxidant defenses: A review. Cell. Death Discov. 11 https:\/\/doi.org\/10.1038\/s41420-024-02278-8 (2025).","DOI":"10.1038\/s41420-024-02278-8"},{"key":"52769_CR4","doi-asserted-by":"publisher","unstructured":"Valgimigli, L. Lipid peroxidation and antioxidant protection. Biomolecules. 13 https:\/\/doi.org\/10.3390\/biom13091291 (2023).","DOI":"10.3390\/biom13091291"},{"key":"52769_CR5","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1039\/d3ra07325d","volume":"14","author":"ZC Dong","year":"2024","unstructured":"Dong, Z. C. et al. Synthesis and pharmacological activity of vinpocetine derivatives. RSC Adv. 14, 7981\u20137991. https:\/\/doi.org\/10.1039\/d3ra07325d (2024).","journal-title":"RSC Adv."},{"key":"52769_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2017.11.041","volume":"819","author":"YS Zhang","year":"2018","unstructured":"Zhang, Y. S., Li, J. D. & Yan, C. An update on vinpocetine: New discoveries and clinical implications. Eur. J. Pharmacol. 819, 30\u201334. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.041 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"52769_CR7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1556\/oh.2007.28115","volume":"148","author":"E Bagoly","year":"2007","unstructured":"Bagoly, E., Feh\u00e9r, G. & Szap\u00e1ry, L. The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies. Orv. Hetil. 148, 1353\u20131358. https:\/\/doi.org\/10.1556\/oh.2007.28115 (2007).","journal-title":"Orv. Hetil."},{"key":"52769_CR8","doi-asserted-by":"publisher","unstructured":"Alshehri, A. A. et al. The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis. J. Inflamm. (Lond). 21 https:\/\/doi.org\/10.1186\/s12950-024-00394-x (2024).","DOI":"10.1186\/s12950-024-00394-x"},{"key":"52769_CR9","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s10787-024-01529-5","volume":"32","author":"MH Abu-Alghayth","year":"2024","unstructured":"Abu-Alghayth, M. H. et al. Atheroprotective role of vinpocetine: An old drug with new indication. Inflammopharmacology 32, 3669\u20133678. https:\/\/doi.org\/10.1007\/s10787-024-01529-5 (2024).","journal-title":"Inflammopharmacology"},{"key":"52769_CR10","doi-asserted-by":"publisher","first-page":"118434","DOI":"10.1016\/j.biopha.2025.118434","volume":"190","author":"G Nan","year":"2025","unstructured":"Nan, G. et al. Vinpocetine alleviates chemotherapy-induced peripheral neuropathy by reducing oxidative stress and enhancing mitochondrial biogenesis in mice. Biomed. Pharmacother. 190, 118434. https:\/\/doi.org\/10.1016\/j.biopha.2025.118434 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"52769_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10557-017-6719-0","volume":"31","author":"MP Wu","year":"2017","unstructured":"Wu, M. P. et al. Vinpocetine attenuates pathological cardiac remodeling by inhibiting cardiac hypertrophy and fibrosis. Cardiovasc. Drugs Ther. 31, 157\u2013166. https:\/\/doi.org\/10.1007\/s10557-017-6719-0 (2017).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"52769_CR12","doi-asserted-by":"publisher","unstructured":"Ozhan, O. et al. Protective effects of buloxibutid and empagliflozin on hypertension-induced cardiac and vascular injury in rats. J. Mol. Histol. 57 https:\/\/doi.org\/10.1007\/s10735-025-10708-9 (2026).","DOI":"10.1007\/s10735-025-10708-9"},{"key":"52769_CR13","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1038\/s41598-025-33721-0","volume":"16","author":"O Ozhan","year":"2025","unstructured":"Ozhan, O. et al. The effects of apocynin on ciprofloxacin-induced oxidative stress-related cardiotoxicity. Sci. Rep. 16, 3702. https:\/\/doi.org\/10.1038\/s41598-025-33721-0 (2025).","journal-title":"Sci. Rep."},{"key":"52769_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/fcp.12599","volume":"35","author":"O Ozhan","year":"2021","unstructured":"Ozhan, O., Parlakpinar, H. & Acet, A. Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats. Fundam. Clin. Pharmacol. 35, 669\u2013680. https:\/\/doi.org\/10.1111\/fcp.12599 (2021).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"52769_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12012-020-09590-6","volume":"21","author":"Z Ulutas","year":"2021","unstructured":"Ulutas, Z. et al. The protective effects of compound 21 and valsartan in isoproterenol-induced myocardial injury in rats. Cardiovasc. Toxicol. 21, 17\u201328. https:\/\/doi.org\/10.1007\/s12012-020-09590-6 (2021).","journal-title":"Cardiovasc. Toxicol."},{"key":"52769_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.14744\/nci.2025.29566","volume":"12","author":"OM Disli","year":"2025","unstructured":"Disli, O. M. et al. Effects of CAPE on biochemical, histopathological and cardiac parameters in doxorubicin induced cardiotoxicity. North. Clin. Istanbul. 12, 587\u2013596. https:\/\/doi.org\/10.14744\/nci.2025.29566 (2025).","journal-title":"North. Clin. Istanbul"},{"key":"52769_CR17","doi-asserted-by":"publisher","unstructured":"Akca, B. et al. Curcumin alleviates doxorubicin-induced cardiotoxicity by modulating apelin expression. Biomolecules 15 https:\/\/doi.org\/10.3390\/biom15101416 (2025).","DOI":"10.3390\/biom15101416"},{"key":"52769_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/10520295.2023.2187461","volume":"98","author":"N Ermis","year":"2023","unstructured":"Ermis, N. et al. Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure. Biotech. Histochem. 98, 326\u2013335. https:\/\/doi.org\/10.1080\/10520295.2023.2187461 (2023).","journal-title":"Biotech. Histochem."},{"key":"52769_CR19","doi-asserted-by":"publisher","unstructured":"Arrigoni, R., Jirillo, E. & Caiati, C. Pathophysiology of doxorubicin-mediated cardiotoxicity. Toxics 13 https:\/\/doi.org\/10.3390\/toxics13040277 (2025).","DOI":"10.3390\/toxics13040277"},{"key":"52769_CR20","doi-asserted-by":"publisher","unstructured":"Vitale, R., Marzocco, S. & Popolo, A. Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: A brief account. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms25137477 (2024).","DOI":"10.3390\/ijms25137477"},{"issue":"1","key":"52769_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch, G. Myocardial ischemia\/reperfusion: Translational pathophysiology of ischemic heart disease. Med 5 (1), 10\u201331. https:\/\/doi.org\/10.1016\/j.medj.2023.12.007 (2024).","journal-title":"Med"},{"key":"52769_CR22","unstructured":"National Research, C. Guide for the Care and Use of Laboratory Animals, 8th edn (National Academies Press, 2011)."},{"key":"52769_CR23","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLoS Biol."},{"key":"52769_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Mihara","year":"1978","unstructured":"Mihara, M. & Uchiyama, M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271\u2013278. https:\/\/doi.org\/10.1016\/0003-2697(78)90342-1 (1978).","journal-title":"Anal. Biochem."},{"key":"52769_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6 (1959).","journal-title":"Arch. Biochem. Biophys."},{"key":"52769_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/clinchem\/34.3.497","volume":"34","author":"Y Sun","year":"1988","unstructured":"Sun, Y., Oberley, L. W. & Li, Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34, 497\u2013500 (1988).","journal-title":"Clin. Chem."},{"key":"52769_CR27","doi-asserted-by":"crossref","unstructured":"L\u00fcck, H. In Methods of Enzymatic Analysis, 885\u2013894 (eds Bergmeyer, H. U.) (Academic, 1965).","DOI":"10.1016\/B978-0-12-395630-9.50158-4"},{"key":"52769_CR28","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/S0021-9258(18)57155-6","volume":"176","author":"A Hiller","year":"1948","unstructured":"Hiller, A., Greif, R. L. & Beckman, W. W. Determination of protein in urine by the biuret method. J. Biol. Chem. 176, 1421\u20131429 (1948).","journal-title":"J. Biol. Chem."},{"key":"52769_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ppul.20131","volume":"39","author":"EA Ozer","year":"2005","unstructured":"Ozer, E. A. et al. Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. Pediatr. Pulmonol. 39, 35\u201340. https:\/\/doi.org\/10.1002\/ppul.20131 (2005).","journal-title":"Pediatr. Pulmonol."},{"key":"52769_CR30","doi-asserted-by":"publisher","unstructured":"Kciuk, M. et al. Doxorubicin\u2014An agent with multiple mechanisms of anticancer activity. Cells. 12 https:\/\/doi.org\/10.3390\/cells12040659 (2023).","DOI":"10.3390\/cells12040659"},{"key":"52769_CR31","doi-asserted-by":"publisher","unstructured":"Bhutani, V. et al. Doxorubicin-induced cardiotoxicity: A comprehensive update. J. Cardiovasc. Dev. Dis. 12 https:\/\/doi.org\/10.3390\/jcdd12060207 (2025).","DOI":"10.3390\/jcdd12060207"},{"key":"52769_CR32","doi-asserted-by":"publisher","unstructured":"Li, S., Li, W., Cheng, M., Wang, X. & Chen, W. Prevention and treatment of anthracycline-induced cardiotoxicity: A systematic review and network meta-analysis of randomized controlled trials. Cardio-oncology. https:\/\/doi.org\/10.1186\/s40959-025-00360-3 (2025).","DOI":"10.1186\/s40959-025-00360-3"},{"key":"52769_CR33","doi-asserted-by":"publisher","unstructured":"Palvia, A. et al. Cardio-oncology\u2019s modern approaches to prevent doxorubicin-induced cardiotoxicity: A systematic review. Cureus 16 https:\/\/doi.org\/10.7759\/cureus.66215 (2024).","DOI":"10.7759\/cureus.66215"},{"key":"52769_CR34","doi-asserted-by":"publisher","unstructured":"Neiman, Z., Legasto, C., Chin, A., Guan, T. & Schulte, B. Utilization of dexrazoxane in patients treated with doxorubicin: A retrospective, propensity matched analysis of cardiac function and toxicity. Front. Oncol. 15 https:\/\/doi.org\/10.3389\/fonc.2025.1621409 (2025).","DOI":"10.3389\/fonc.2025.1621409"},{"key":"52769_CR35","doi-asserted-by":"publisher","unstructured":"Khafaji, A. T. A., Barakat, A., Shayyal, A. J., Taan, A. A. & Al-Aouadi, R. F. A. Managing doxorubicin cardiotoxicity: insights into molecular mechanisms and protective strategies. J. Biochem. Mol. Toxicol. 39 https:\/\/doi.org\/10.1002\/jbt.70155 (2025).","DOI":"10.1002\/jbt.70155"},{"key":"52769_CR36","doi-asserted-by":"publisher","unstructured":"Refaie, M. et al. Phosphodiesterase inhibitor, Vinpocetine, guards against doxorubicin induced cardiotoxicity via modulation of HIF\/VEGF and cGMP\/cAMP\/SIRT signaling pathways. Hum. Exp. Toxicol. 41 https:\/\/doi.org\/10.1177\/09603271221136209 (2022).","DOI":"10.1177\/09603271221136209"},{"key":"52769_CR37","first-page":"629","volume":"6","author":"G\u00dc Taner","year":"2017","unstructured":"Taner, G. \u00dc., Ediz, V. E. N. M., Hakan, S., Nigar, P., Kevser, T. & V. & Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. Med. Sci. 6, 629\u2013634 (2017).","journal-title":"Med. Sci."},{"key":"52769_CR38","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","volume":"18","author":"C Kong","year":"2022","unstructured":"Kong, C. et al. Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death. Int. J. Biol. Sci. 18, 760\u2013770. https:\/\/doi.org\/10.7150\/ijbs.65258 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"52769_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.119.314681","author":"K Wallace","year":"2020","unstructured":"Wallace, K., Sard\u00e3o, V. & Oliveira, P. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circul. Res. https:\/\/doi.org\/10.1161\/circresaha.119.314681 (2020).","journal-title":"Circul. Res."},{"key":"52769_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","volume":"34","author":"FS Carvalho","year":"2014","unstructured":"Carvalho, F. S. et al. Doxorubicin-induced cardiotoxicity: From bioenergetic failure and cell death to cardiomyopathy. Med. Res. Rev. 34, 106\u2013135. https:\/\/doi.org\/10.1002\/med.21280 (2014).","journal-title":"Med. Res. Rev."},{"key":"52769_CR41","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s12012-025-09995-1","volume":"25","author":"D Liu","year":"2025","unstructured":"Liu, D. et al. Protein kinase C epsilon overexpression protects the heart against doxorubicin-induced cardiotoxicity via activating SIRT1. Cardiovasc. Toxicol. 25, 915\u2013928. https:\/\/doi.org\/10.1007\/s12012-025-09995-1 (2025).","journal-title":"Cardiovasc. Toxicol."},{"key":"52769_CR42","doi-asserted-by":"publisher","first-page":"e23393","DOI":"10.1002\/jbt.23393","volume":"37","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Bradykinin receptor participates in doxorubicin-induced cardiotoxicity by modulating iNOS signal pathway. J. Biochem. Mol. Toxicol. 37, e23393. https:\/\/doi.org\/10.1002\/jbt.23393 (2023).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"52769_CR43","first-page":"195","volume":"58 2","author":"E Herman","year":"1998","unstructured":"Herman, E. et al. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res. 58 2, 195\u2013197 (1998).","journal-title":"Cancer Res."},{"key":"52769_CR44","doi-asserted-by":"publisher","unstructured":"Ran, T. et al. Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials. PLoS One. 19 https:\/\/doi.org\/10.1371\/journal.pone.0303208 (2024).","DOI":"10.1371\/journal.pone.0303208"},{"key":"52769_CR45","doi-asserted-by":"publisher","unstructured":"Lazar, D. et al. Anthracycline\u2019s effects on heart rate variability in children with acute lymphoblastic leukemia: Early toxicity signs\u2014Pilot study. J. Clin. Med. 12 https:\/\/doi.org\/10.3390\/jcm12227052 (2023).","DOI":"10.3390\/jcm12227052"},{"key":"52769_CR46","doi-asserted-by":"publisher","unstructured":"Yu, H. et al. Anthracycline induced cardiac disorders in childhood acute lymphoblastic leukemia: A single-centre, retrospective, observational study. Front. Pharmacol. 12 https:\/\/doi.org\/10.3389\/fphar.2021.598708 (2021).","DOI":"10.3389\/fphar.2021.598708"},{"key":"52769_CR47","doi-asserted-by":"publisher","DOI":"10.15407\/fz70.01.003","author":"MV Denysova","year":"2024","unstructured":"Denysova, M. V. et al. Fiziolohichny\u012d zhurnal. https:\/\/doi.org\/10.15407\/fz70.01.003 (2024).","journal-title":"Fiziolohichny\u012d zhurnal"},{"key":"52769_CR48","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00210-023-02382-z","volume":"396","author":"P Dulf","year":"2023","unstructured":"Dulf, P. et al. Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in a murine model. Naunyn. Schmiedebergs Arch. Pharmacol. 396, 1105\u20131115. https:\/\/doi.org\/10.1007\/s00210-023-02382-z (2023).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"52769_CR49","doi-asserted-by":"publisher","DOI":"10.35440\/hutfd.1403862","author":"Y G\u00f6k\u00e7e","year":"2024","unstructured":"G\u00f6k\u00e7e, Y., Dan\u0131\u015fman, B. & Cicek, B. Evaluating the effects of acute and chronic doxorubicin administration on cardiac function through electrocardiographic measurements. Harran \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi. https:\/\/doi.org\/10.35440\/hutfd.1403862 (2024).","journal-title":"Harran \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi"},{"key":"52769_CR50","doi-asserted-by":"publisher","unstructured":"Warhol, A., George, S., Obaid, S., Efimova, T. & Efimov, I. Differential cardiotoxic electrocardiographic response to doxorubicin treatment in conscious versus anesthetized mice. Physiol. Rep. 9 https:\/\/doi.org\/10.14814\/phy2.14987 (2021).","DOI":"10.14814\/phy2.14987"},{"issue":"1","key":"52769_CR51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/toxsci\/kfp092","volume":"110","author":"M Hazari","year":"2009","unstructured":"Hazari, M., Haykal-Coates, N., Winsett, D., Costa, D. & Farraj, A. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin. Toxicol. Sci. 110 (1), 224\u2013234. https:\/\/doi.org\/10.1093\/toxsci\/kfp092 (2009).","journal-title":"Toxicol. Sci."},{"key":"52769_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/mol.119.115725","volume":"96","author":"N Wenningmann","year":"2019","unstructured":"Wenningmann, N., Knapp, M., Ande, A., Vaidya, T. & Ait-Oudhia, S. Insights into doxorubicin-induced cardiotoxicity: Molecular mechanisms, preventive strategies, and early monitoring. Mol. Pharmacol. 96, 219\u2013232. https:\/\/doi.org\/10.1124\/mol.119.115725 (2019).","journal-title":"Mol. Pharmacol."},{"key":"52769_CR53","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-52751\/v1","author":"T Kinoshita","year":"2020","unstructured":"Kinoshita, T. et al. Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity. J. Cardiol. https:\/\/doi.org\/10.21203\/rs.3.rs-52751\/v1 (2020).","journal-title":"J. Cardiol."},{"key":"52769_CR54","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1111\/bph.70085","volume":"182","author":"JSA van der Geest","year":"2025","unstructured":"van der Geest, J. S. A. et al. Dexrazoxane protects against doxorubicin-induced cardiotoxicity in susceptible human living myocardial slices: A proof-of-concept study. Br. J. Pharmacol. 182, 4262\u20134280. https:\/\/doi.org\/10.1111\/bph.70085 (2025).","journal-title":"Br. J. Pharmacol."},{"key":"52769_CR55","doi-asserted-by":"publisher","unstructured":"Afonso, A., Amaro-Leal, \u00c2., Machado, F., Rocha, I. & Geraldes, V. Doxorubicin dose-dependent impact on physiological balance\u2014A holistic approach in a rat model. Biology 12 https:\/\/doi.org\/10.3390\/biology12071031 (2023).","DOI":"10.3390\/biology12071031"},{"key":"52769_CR56","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3923\/ijp.2017.1098.1102","volume":"13","author":"N Younis","year":"2017","unstructured":"Younis, N., Ahmed, A., Mulhim, N. A., Algarni, A. & Madu, E. Exenatide attenuation of cardiac rhythm abnormalities and blood pressure changes induced by doxorubicin in rats. Int. J. Pharmacol. 13, 1098\u20131102. https:\/\/doi.org\/10.3923\/ijp.2017.1098.1102 (2017).","journal-title":"Int. J. Pharmacol."},{"key":"52769_CR57","doi-asserted-by":"publisher","DOI":"10.15829\/1560-4071-2025-5920","author":"T Satalkina","year":"2025","unstructured":"Satalkina, T., Brodskaya, T., Geltser, B. & Kotelnikov, V. Arterial stiffness and 24-hour blood pressure profile in women with breast cancer before and after chemotherapy with doxorubicin and cyclophosphamide. Russian J. Cardiol. https:\/\/doi.org\/10.15829\/1560-4071-2025-5920 (2025).","journal-title":"Russian J. Cardiol."},{"key":"52769_CR58","doi-asserted-by":"publisher","unstructured":"Anagnostopoulos, C. et al. P.42 The effects of chemotherapy on arterial stiffness in patients with hodgkin lymphoma. Artery Res. 26 https:\/\/doi.org\/10.2991\/artres.k.201209.054 (2020).","DOI":"10.2991\/artres.k.201209.054"},{"key":"52769_CR59","doi-asserted-by":"publisher","unstructured":"Mas-Bargues, C., Escriv\u00e1, C., Dromant, M., Borr\u00e1s, C. & Vi\u00f1a, J. Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease. Arch. Biochem. Biophys. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.12.325 (2021).","DOI":"10.1016\/j.freeradbiomed.2020.12.325"},{"key":"52769_CR60","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1083\/jcb.201708007","volume":"217","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Branicky, R., No\u00eb, A. & Hekimi, S. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. J. Cell Biol. 217, 1915\u20131928. https:\/\/doi.org\/10.1083\/jcb.201708007 (2018).","journal-title":"J. Cell Biol."},{"key":"52769_CR61","doi-asserted-by":"publisher","unstructured":"Anwar, S. et al. Exploring therapeutic potential of catalase: Strategies in disease prevention and management. Biomolecules 14 https:\/\/doi.org\/10.3390\/biom14060697 (2024).","DOI":"10.3390\/biom14060697"},{"key":"52769_CR62","doi-asserted-by":"publisher","unstructured":"Georgiou-Siafis, S. & Tsiftsoglou, A. The key role of GSH in keeping the redox balance in mammalian cells: Mechanisms and significance of GSH in detoxification via formation of conjugates. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12111953 (2023).","DOI":"10.3390\/antiox12111953"},{"key":"52769_CR63","doi-asserted-by":"publisher","first-page":"101285","DOI":"10.1016\/j.genrep.2021.101285","volume":"24","author":"N Hadi","year":"2021","unstructured":"Hadi, N., Mahmood, R. & Al-Saffar, A. Evaluation of antioxidant enzyme activity in doxorubicin treated breast cancer patients in Iraq: A molecular and cytotoxic study. Gene Rep. 24, 101285. https:\/\/doi.org\/10.1016\/j.genrep.2021.101285 (2021).","journal-title":"Gene Rep."},{"key":"52769_CR64","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tox.2004.12.003","volume":"209 1","author":"Y Kalender","year":"2005","unstructured":"Kalender, Y., Yel, M. & Kalender, S. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology 209 1, 39\u201345. https:\/\/doi.org\/10.1016\/j.tox.2004.12.003 (2005).","journal-title":"Toxicology"},{"key":"52769_CR65","doi-asserted-by":"publisher","unstructured":"Szwed, M., Kania, K. & J\u00f3\u017awiak, Z. Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate. Biochimie 107 Pt B. 358\u2013366. https:\/\/doi.org\/10.1016\/j.biochi.2014.10.005 (2014).","DOI":"10.1016\/j.biochi.2014.10.005"},{"key":"52769_CR66","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Barrera, L. et al. Modification of proliferation and apoptosis in breast cancer cells by exposure of antioxidant nanoparticles due to modulation of the cellular redox state induced by doxorubicin exposure. Pharmaceutics. 13 https:\/\/doi.org\/10.3390\/pharmaceutics13081251 (2021).","DOI":"10.3390\/pharmaceutics13081251"},{"key":"52769_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/15287394.2024.2448663","volume":"88","author":"J Pereira","year":"2025","unstructured":"Pereira, J. et al. Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines. J. Toxicol. Environ. Health Part. A. 88, 409\u2013431. https:\/\/doi.org\/10.1080\/15287394.2024.2448663 (2025).","journal-title":"J. Toxicol. Environ. Health Part. A"},{"key":"52769_CR68","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s11064-011-0450-1","volume":"36","author":"O Abdel-Salam","year":"2011","unstructured":"Abdel-Salam, O., Khadrawy, Y., Salem, N. & Sleem, A. Oxidative stress in a model of toxic demyelination in rat brain: The effect of piracetam and vinpocetine. Neurochem. Res. 36, 1062\u20131072. https:\/\/doi.org\/10.1007\/s11064-011-0450-1 (2011).","journal-title":"Neurochem. Res."},{"key":"52769_CR69","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00580-015-2182-0","volume":"25","author":"O Abdel-Salam","year":"2016","unstructured":"Abdel-Salam, O. et al. Effect of piracetam, vincamine, vinpocetine, and donepezil on oxidative stress and neurodegeneration induced by aluminum chloride in rats. Comp. Clin. Pathol. 25, 305\u2013318. https:\/\/doi.org\/10.1007\/s00580-015-2182-0 (2016).","journal-title":"Comp. Clin. Pathol."},{"key":"52769_CR70","doi-asserted-by":"publisher","unstructured":"Zhang, H. J., Fu, Y., Zhang, H., Lai, Z. Q. & Dong, Y. F. Sophocarpine alleviates doxorubicin-induced heart injury by suppressing oxidative stress and apoptosis. Sci. Rep. 14 https:\/\/doi.org\/10.1038\/s41598-023-51083-3 (2024).","DOI":"10.1038\/s41598-023-51083-3"},{"key":"52769_CR71","doi-asserted-by":"publisher","unstructured":"Podyacheva, E., Kushnareva, E., Karpov, A. & Toropova, Y. Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician. Front. Pharmacol. 12 https:\/\/doi.org\/10.3389\/fphar.2021.670479 (2021).","DOI":"10.3389\/fphar.2021.670479"},{"key":"52769_CR72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1254\/jphs.fp0050980","volume":"101 2","author":"M Ueno","year":"2006","unstructured":"Ueno, M. et al. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J. Pharmacol. Sci. 101 2, 151\u2013158. https:\/\/doi.org\/10.1254\/jphs.fp0050980 (2006).","journal-title":"J. Pharmacol. Sci."},{"key":"52769_CR73","doi-asserted-by":"publisher","unstructured":"Malik, A., Bagchi, A., Jassal, D. & Singal, P. Interleukin-10 mitigates doxorubicin-induced endoplasmic reticulum stress as well as cardiomyopathy. Biomedicines 10 https:\/\/doi.org\/10.3390\/biomedicines10040890 (2022).","DOI":"10.3390\/biomedicines10040890"},{"key":"52769_CR74","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-005-9072-8","volume":"285","author":"Y Cigremis","year":"2006","unstructured":"Cigremis, Y. et al. Beneficial role of aminoguanidine on acute cardiomyopathy related to doxorubicin-treatment. Mol. Cell. Biochem. 285, 149\u2013154. https:\/\/doi.org\/10.1007\/s11010-005-9072-8 (2006).","journal-title":"Mol. Cell. Biochem."},{"key":"52769_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1034\/j.1600-079x.2003.00084.x","volume":"35","author":"E Sahna","year":"2003","unstructured":"Sahna, E. et al. Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J. Pineal Res. 35, 257\u2013261. https:\/\/doi.org\/10.1034\/j.1600-079x.2003.00084.x (2003).","journal-title":"J. Pineal Res."},{"key":"52769_CR76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000354807","volume":"51","author":"OM Disli","year":"2013","unstructured":"Disli, O. M. et al. Effects of molsidomine against doxorubicin-induced cardiotoxicity in rats. Eur. Surg. Res. Europaische chirurgische Forschung Recherches chirurgicales europeennes. 51, 79\u201390. https:\/\/doi.org\/10.1159\/000354807 (2013).","journal-title":"Eur. Surg. Res. Europaische chirurgische Forschung Recherches chirurgicales europeennes"},{"issue":"3","key":"52769_CR77","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/cphy.c140059","volume":"5","author":"T Tan","year":"2015","unstructured":"Tan, T., Neilan, T., Francis, S., Plana, J. & Scherrer-Crosbie, M. Anthracycline-induced cardiomyopathy in adults. Compr. Physiol. 5 (3), 1517\u20131540. https:\/\/doi.org\/10.1002\/cphy.c140059 (2015).","journal-title":"Compr. Physiol."},{"key":"52769_CR78","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","volume":"104","author":"PA Henriksen","year":"2018","unstructured":"Henriksen, P. A. Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart (British Cardiac Society). 104, 971\u2013977. https:\/\/doi.org\/10.1136\/heartjnl-2017-312103 (2018).","journal-title":"Heart (British Cardiac Society)"},{"key":"52769_CR79","doi-asserted-by":"publisher","unstructured":"Yang, M. et al. Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia\/reperfusion injury in mice. Liver Transpl. 20 https:\/\/doi.org\/10.1002\/lt.23958 (2014).","DOI":"10.1002\/lt.23958"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52769-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:32:06Z","timestamp":1783557126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52769"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52769-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals and ARRIVE criteria were followed in all experiments and procedures conducted for this work\n                      22,23\n                      . An application was made to Inonu University Faculty of Medicine Animal Experiments Local Ethics Committee for ethical approval and ethics committee permission was obtained at the meeting dated 17\/08\/2017 with ethical approval number 2017\/A-43.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"21365"}}